Suivre
Flore GOUEL
Flore GOUEL
Ingénieur de rechercher
Adresse e-mail validée de univ-lille.fr
Titre
Citée par
Citée par
Année
Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC
B Do Van, F Gouel, A Jonneaux, K Timmerman, P Gelé, M Pétrault, ...
Neurobiology of disease 94, 169-178, 2016
5672016
Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis?
C Moreau, V Danel, JC Devedjian, G Grolez, K Timmerman, C Laloux, ...
Antioxidants & redox signaling 29 (8), 742-748, 2018
1032018
Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
D Devos, ZI Cabantchik, C Moreau, V Danel, L Mahoney-Sanchez, ...
Journal of Neural Transmission 127, 189-203, 2020
832020
Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease
ML Chou, JW Wu, F Gouel, A Jonneaux, K Timmerman, TY Renn, ...
Biomaterials 142, 77-89, 2017
502017
Past and future of neurotrophic growth factors therapies in ALS: from single neurotrophic growth factor to stem cells and human platelet lysates
F Gouel, AS Rolland, JC Devedjian, T Burnouf, D Devos
Frontiers in neurology 10, 455919, 2019
472019
The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways
F Gouel, B Do Van, ML Chou, A Jonneaux, C Moreau, R Bordet, ...
Journal of tissue engineering and regenerative medicine 11 (11), 3236-3240, 2017
432017
Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways
C Petit, F Gouel, I Dubus, C Heuclin, K Roget, JP Vannier
BMC cancer 16, 1-17, 2016
422016
Disruption of TCA cycle and glutamate metabolism identified by metabolomics in an in vitro model of amyotrophic lateral sclerosis
C Veyrat-Durebex, P Corcia, E Piver, D Devos, A Dangoumau, F Gouel, ...
Molecular neurobiology 53, 6910-6924, 2016
372016
What role for angiogenesis in childhood acute lymphoblastic leukaemia?
P Schneider, I Dubus, F Gouel, E Legrand, JP Vannier, M Vasse
Advances in hematology 2011, 2011
222011
FAIRPARK-II and FAIRALS-II studygroups. Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
D Devos, ZI Cabantchik, C Moreau, V Danel, L Mahoney-Sanchez, ...
J. Neural Transm 127, 189-203, 2020
202020
Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?
C Laloux, F Gouel, C Lachaud, K Timmerman, B Do Van, A Jonneaux, ...
Neurobiology of disease 103, 24-31, 2017
192017
Rac-1 GTPase controls the capacity of human leukaemic lymphoblasts to migrate on fibronectin in response to SDF-1α (CXCL12)
M Freret, F Gouel, C Buquet, E Legrand, JP Vannier, M Vasse, I Dubus
Leukemia research 35 (7), 971-973, 2011
172011
Whole and fractionated human platelet lysate biomaterials-based biotherapy induces strong neuroprotection in experimental models of amyotrophic lateral sclerosis
F Gouel, K Timmerman, P Gosset, C Raoul, M Dutheil, A Jonneaux, ...
Biomaterials 280, 121311, 2022
102022
Ferroptosis, a recently identified cell death, as a therapeutic target for Parkinson''''s disease
H Bouchaoui, L Mahoney-Sanchez, A Jonneaux, F Gouel, M Dutheil, ...
12019
Importance of local hypoxia on endothelial phenotype for an in vitro approach to bone marrow angiogenesis
F Gouel, S Kamanzi, C Corbière, C Buquet, E Legrand, JP Vannier, ...
Leukemia Research 36 (9), 1200-1203, 2012
12012
Long-term inhibition of lysosomal glucocerebrosidase activity promotes GPX4 stability and inhibits ferroptosis in a Parkinson’s model
MA Bonte, F Gouel, A Jonneaux, K Belarbi, D Devos, JC Devedjian
2024
P07-25 Air pollution-derived ultrafine particles induce ferroptosis in differentiated human dopaminergic neuronal LUHMES cells
E Theerens, O Simonin, H Bouchaoui, A Jonneaux, F Gouel, ...
Toxicology Letters 368, S129-S130, 2022
2022
Pharmacological inhibition of lysosomal glucocerebrosidase activity in experimental cellular models of Parkinson's disease
MA Bonte, Y Yan, R Bordet, D Devos, F Gouel, JC Devedjian, K Belarbi
FUNDAMENTAL & CLINICAL PHARMACOLOGY 36, 73-73, 2022
2022
Ferroptosis, a recently identified cell death, as a therapeutic target for Parkinson's disease
H Bouchaoui, LM Sanchez, A Jonneaux, F Gouel, J Devedjian, D DEVOS, ...
2021
Whole and fractionated human platelet lysate induce neuroprotection in severe amyotrophic lateral sclerosis models
F Gouel, K Timmerman, P Gosset, C Raoul, M Dutheil, A Jonneaux, ...
2021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20